Literature DB >> 25952470

Serum 25-Hydroxyvitamin D Levels: Variability, Knowledge Gaps, and the Concept of a Desirable Range.

Ghada El-Hajj Fuleihan1, Roger Bouillon2, Bart Clarke3, Marlene Chakhtoura1, Cyrus Cooper4, Michael McClung5, Ravinder J Singh3.   

Abstract

Hypovitaminosis D is prevalent worldwide but proportions vary widely between regions, depending on genetic and lifestyle factors, the threshold to define deficiency, and accuracy of 25-hydroxyvitamin D (25OHD) assays used. Latitude, pollution, concealing clothing, sun exposure, gender, dietary habits, and lack of government regulation account for up to 50% in variations in serum 25OHD levels, whereas genetic polymorphisms in the vitamin D pathway account for less than 5%. Organizations/societies have developed guidelines for recommended desirable 25OHD levels and vitamin D doses to reach them, but their applicability across age groups and populations are still debated. This article and the accompanying online Supporting Information highlight sources of variations in circulating 25OHD levels, uncertainties and knowledge gaps, and analytical problems facing 25OHD assays, while keeping efficacy and safety data as the dominant factors when defining a desirable range for 25OHD levels. We propose a desirable range of 20 to 40 ng/mL (50 to 100 nmol/L), provided precise and accurate assays are used. Although slightly lower levels, 15 to 20 ng/mL, may be sufficient for some infants and adults, higher levels, 40 to 60 ng/mL, may still be safe. This desirable range allows physicians to tailor treatment while taking season, lifestyle, vitamin D intake, and other sources of variation into account. We reserve 25OHD measurements for at-risk patients, defined by disease or lifestyle, and the use of 25OHD assays calibrated against the recommended international standards. Most target groups reach desirable target levels by a daily intake of 400 to 600 IU for children and 800 IU for adults. A total daily allowance of vitamin D of up to 1000 IU in the pediatric age groups, and up to 2000 IU in adults, tailored to an individual patient risk profile, is probably safe over long durations. Additional data are needed to validate the proposed range and vitamin D doses, especially in children, pregnant women, and non-white populations.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  DESIRABLE RANGE; EFFICACY; ETHNICITIES; KNOWLEDGE GAPS; SAFETY; VARIATIONS; VITAMIN D

Mesh:

Substances:

Year:  2015        PMID: 25952470     DOI: 10.1002/jbmr.2536

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  64 in total

1.  Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health.

Authors:  Pedro L F Costa; Monica M França; Bruno Ferraz-de-Souza
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

Review 2.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

Review 3.  Impact of vitamin D replacement in adults and elderly in the Middle East and North Africa: a systematic review and meta-analysis of randomized controlled trials.

Authors:  M Chakhtoura; E A Akl; S El Ghandour; K Shawwa; A Arabi; Z Mahfoud; R H Habib; H Hoballah; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2016-11-22       Impact factor: 4.507

4.  Optimal vitamin D supplementation strategies.

Authors:  Roger Bouillon
Journal:  Endocrine       Date:  2017-02-01       Impact factor: 3.633

5.  Effect of vitamin D replacement on indexes of insulin resistance in overweight elderly individuals: a randomized controlled trial.

Authors:  Ghada El-Hajj Fuleihan; Rafic Baddoura; Robert H Habib; Georges Halaby; Asma Arabi; Maya Rahme; Ravinder J Singh; Moustapha Kassem; Ziyad Mahfoud; Maha Hoteit; Rose T Daher; Mohamed-Faisal Kassir
Journal:  Am J Clin Nutr       Date:  2016-07-13       Impact factor: 7.045

6.  CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementation.

Authors:  A Arabi; N Khoueiry-Zgheib; Z Awada; R Mahfouz; L Al-Shaar; M Hoteit; M Rahme; R Baddoura; G Halabi; R Singh; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2016-07-30       Impact factor: 4.507

7.  Impact of Calcium and Two Doses of Vitamin D on Bone Metabolism in the Elderly: A Randomized Controlled Trial.

Authors:  Maya Rahme; Sima Lynn Sharara; Rafic Baddoura; Robert H Habib; Georges Halaby; Asma Arabi; Ravinder J Singh; Moustapha Kassem; Ziyad Mahfoud; Maha Hoteit; Rose T Daher; Darina Bassil; Karim El Ferkh; Ghada El-Hajj Fuleihan
Journal:  J Bone Miner Res       Date:  2017-05-18       Impact factor: 6.741

8.  Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria.

Authors:  Serwet Demirdas; Francjan J van Spronsen; Carla E M Hollak; J Hanneke van der Lee; Peter H Bisschop; Fred M Vaz; Nienke M Ter Horst; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  Ann Nutr Metab       Date:  2017-03-24       Impact factor: 3.374

9.  Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.

Authors:  S Minisola; L Cianferotti; P Biondi; C Cipriani; C Fossi; F Franceschelli; F Giusti; G Leoncini; J Pepe; H A Bischoff-Ferrari; M L Brandi
Journal:  Osteoporos Int       Date:  2017-08-16       Impact factor: 4.507

10.  Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.

Authors:  M Li; F Lv; Z Zhang; W Deng; Y Li; Z Deng; Y Jiang; O Wang; X Xing; L Xu; W Xia
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.